Vascular protection to increase the safety of tissue plasminogen activator for stroke - Wikidata - awgldk - TriplyDB

Vascular protection to increase the safety of tissue plasminogen activator for stroke

Vascular protection to increase the safety of tissue plasminogen activator for stroke

http://www.wikidata.org/entity/Q26824338

about

Meta-analysis of Vascular Imaging Features to Predict Outcome Following Intravenous rtPA for Acute Ischemic Stroke Modulating Astrocyte Transition after Stroke to Promote Brain Rescue and Functional Recovery: Emerging Targets Include Rho Kinase Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke.Hemorrhagic transformation after ischemic stroke in animals and humans Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need.One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke.Breaking the barrier in stroke: what should we know? A mini-review.Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.Refocusing Neuroprotection in Cerebral Reperfusion Era: New Challenges and Strategies.Futile Recanalization after Endovascular Therapy in Acute Ischemic Stroke.

P2860

Q26744701-53FD9DF2-32E7-4823-A236-753C87730377 Q28075887-50A52B7F-D543-433E-A8B6-B103EEC2ED1D Q36026755-E68299A9-FA9B-472D-A2B4-E16A77CF5A59 Q37559355-2D397813-F904-41C0-B559-19E4B40976EF Q37640874-741824EE-3EFE-451C-ADAA-FACDE7372B12 Q37668019-89354700-383D-4150-8055-C241870D73F2 Q38009070-F440FF73-F217-4C60-9C58-3D26BE1A544F Q38592712-98625934-0203-4DE9-8629-40AB304898CC Q54967560-19F3745B-021D-4D5B-B53D-21F04841709D Q55019366-5EBB02F1-F73E-4D43-B8C6-B0D694FCD05B

P2860

Vascular protection to increase the safety of tissue plasminogen activator for stroke

http://www.wikidata.org/entity/Q26824338

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@ast

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@en

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@nl

type

label

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@ast

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@en

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@nl

prefLabel

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@ast

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@en

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@nl

P1433

Q26824338-97E37EFE-875D-47DE-8398-F26A027A5EA8

P1476

Q26824338-C53E2B7B-7FDD-4BD0-976F-CE3D87C68795

P2093

Q26824338-0F42D911-8FB3-4D55-AC79-E5E0F4797AD8

Q26824338-41D0B26A-696B-4F59-B08B-4C6EA720C4DB

Q26824338-6776824A-70F5-4427-8EAD-EC4BD4568B7A

Q26824338-BB1C337B-D217-475E-82A5-C6DF89CE0858

Q26824338-E4D455AB-7C95-418D-9637-EBB07CA06CA7

P2860

Q26824338-00309B53-BC16-42ED-9543-DFFFB9E4E593

Q26824338-0124C9F9-88FC-4213-BB3E-C61ACAB84023

Q26824338-04ACDF83-9E8F-415C-94B6-39970380E1EC

Q26824338-06700CF4-93FE-43B2-AA2E-0ADE5A8DDBF2

Q26824338-07AEB977-26DC-44E3-A3F7-B015A647165A

Q26824338-096ACBF3-2A69-4944-8CFC-CADC3422E4FF

Q26824338-0E3F2296-9EC4-480C-9150-81B54EDBB9EA

Q26824338-0FCE333A-37E7-4555-A69E-294734FBFB42

Q26824338-123AA114-B5EC-45AD-B271-0F07DE458407

Q26824338-12F9946B-B5F0-4156-99CF-B74F73FA404B

P304

Q26824338-E0EFEFD6-90FF-4552-987D-4F4A9B6D1BDD

P31

Q26824338-E312BBF6-7D7F-41C8-95A5-1E170FCD62EB

P3181

Q26824338-027210A1-8088-4B85-8A0E-0E831B497FF9

P356

Q26824338-2EE88FB5-06A4-414E-92C8-DF5604DAE567

P407

Q26824338-48F902B1-BDE8-45DA-B85E-D0BA28BAAB51

P433

Q26824338-80383637-C6C8-4CB0-A161-432BEEB37C1B

P478

Q26824338-3FA8F2FA-2C73-43AB-93C2-01F02BDF9984

P577

Q26824338-8CE6A9D6-5856-440F-B740-7F0317C02834

P5875

Q26824338-42C2B70A-3DF0-4124-B8D5-E5F27531D670

P698

Q26824338-48ECE0F0-8D04-4BB4-B4AF-BE8A36956295

P932

Q26824338-E517189E-0DA3-4F60-BB5F-EEB58F705E25

P3181

P356

138161212802002779

P1433

Current Pharmaceutical Design

P1476

Vascular protection to increase the safety of tissue plasminogen activator for stroke

@en

P2093

Fagan SC

http://www.w3.org/2001/XMLSchema#string

Guan W

http://www.w3.org/2001/XMLSchema#string

Ishrat T

http://www.w3.org/2001/XMLSchema#string

Saler M

http://www.w3.org/2001/XMLSchema#string

Soliman S

http://www.w3.org/2001/XMLSchema#string

P2860

Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC

The LDL receptor gene family: (un)expected signal transducers in the brain

Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia

NXY-059 for acute ischemic stroke

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats.

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.

Attenuation of extravasation of tissue plasminogen activator by the free radical scavenger, edaravone: evaluation in a rat thromboembolic stroke model.

P304

3677-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1543794

http://www.w3.org/2001/XMLSchema#string

P356

10.2174/138161212802002779

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224938292

http://www.w3.org/2001/XMLSchema#string

P698

22574982

http://www.w3.org/2001/XMLSchema#string

P932

3602899

http://www.w3.org/2001/XMLSchema#string